Skip to main content
Clinical Trials/NL-OMON51834
NL-OMON51834
Not yet recruiting
Not Applicable

ongitudinal variation of blood based biomarkers in moderate-to-severe atopic dermatitis patients, a prospective cohort study - BIOMAD study

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
Erasmus MC, Universitair Medisch Centrum Rotterdam
Enrollment
260
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational non invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • \- Adult patients with moderate\-to\-severe atopic dermatitis
  • \- An intention to start cyclosporine A, dupilumab, tralokinumab, oral
  • JAK\-inhibitor (abrocitinib or upadacitinib) treatment according to the NVDV
  • \- Documented recent history (last 6 months) of eligibility for treatment with
  • immunosuppressants, biologicals and JAK\-inhibitors.

Exclusion Criteria

  • \- Children and adolescents (\<18 years)
  • \- men and women planning pregnancy during study, pregnant women and
  • breastfeeding women
  • \- Patients with other inflammatory skin diseases, autoimmune diseases, or other
  • inflammatory diseases will be excluded (eg. psoriasis, diabetes mellitus,
  • inflammatory bowel
  • disease, rheumatoid arthrtitis).

Outcomes

Primary Outcomes

Not specified

Similar Trials